| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥1801.9B | ¥1858.5B | -3.0% |
| Operating Income | ¥265.2B | ¥164.0B | +61.7% |
| Ordinary Income | ¥275.5B | ¥169.8B | +62.3% |
| Net Income | ¥193.5B | ¥121.1B | +59.8% |
| ROE | 15.9% | 11.1% | - |
FY2026 Q3 consolidated results show revenue of 180.2B yen (YoY -3.0%), operating income of 26.5B yen (+61.7%), ordinary income of 27.6B yen (+62.3%), and net income attributable to owners of 19.4B yen (+59.8%). While revenue declined moderately due to completion of large-scale projects in the prior period, profitability improved dramatically through enhanced gross profit margins driven by appropriate pricing transfers. The company achieved a gross profit margin of 23.1% (up 7.5pt YoY), expanding gross profit by 12.6B yen to 41.7B yen. Short-term borrowings decreased substantially from 22.9B yen to 2.8B yen (-88.0%), while cash holdings increased 32.9% to 68.8B yen, significantly improving liquidity. Full-year guidance was revised upward with operating income forecast at 32.0B yen (+38.9% YoY) and net income at 23.1B yen, supported by robust order backlogs reaching a record high of 323.2B yen (+24.4%).
Revenue declined 3.0% to 180.2B yen primarily due to the absence of large construction projects completed in the prior period. However, this was more than offset by significant margin expansion. The gross profit margin improved dramatically from 15.6% to 23.1%, an increase of 7.5 percentage points, driven by successful price escalation reflecting appropriate transfer of labor and material cost increases to customers. This resulted in gross profit expansion of 12.6B yen to 41.7B yen, which directly flowed through to operating income.
Operating income increased 61.7% to 26.5B yen, representing an operating margin of 14.7% (up from 8.8% YoY). The improvement was primarily due to the aforementioned gross margin expansion, though partially offset by a 1.7B yen increase in selling, general and administrative expenses to 15.1B yen, mainly from employee salary increases associated with base-up initiatives and ongoing digital transformation investments.
Non-operating income contributed 1.2B yen (including 0.5B yen foreign exchange gains), while interest expense remained minimal at 0.08B yen due to the substantial reduction in interest-bearing debt. This resulted in ordinary income of 27.6B yen (+62.3%).
The gap between ordinary income (27.6B yen) and net income (19.2B yen) represents 30.4%, primarily attributable to income taxes of 8.9B yen. Extraordinary items were minimal, with extraordinary income of 0.5B yen (mainly 0.4B yen gain on sales of investment securities) and extraordinary losses of 0.05B yen, indicating no material non-recurring factors affecting core profitability.
This represents a "revenue down, profit up" pattern, where operational efficiency gains and pricing power more than compensated for volume decline, reflecting successful business model optimization focused on profitability over top-line growth.
Air-conditioning and Sanitation Works segment, the core business, recorded orders of 178.2B yen (+2.8%) and completed construction of 146.2B yen (-9.8%). The decline in completed work reflects the absence of large-scale projects from the prior period, though underlying demand from public facilities and urban redevelopment projects remained solid. Order backlog grew 14.3% to 255.4B yen, providing strong revenue visibility. This segment accounts for approximately 81% of total revenue.
Electrical Works segment showed exceptional growth with orders of 66.8B yen (+105.8%) and completed construction of 34.0B yen (+42.8%). The surge was driven by large overseas medical facility projects, particularly following the consolidation of Presico (Singapore). Order backlog expanded 86.5% to 67.7B yen, representing approximately 19% of total revenue. This segment is becoming an increasingly important growth driver.
Overseas operations recorded orders of 49.3B yen (+80.0%), representing 20.1% of total orders. The expansion reflects large-scale orders for research facilities and medical-related projects in Singapore, plus the consolidation impact of Presico. Overseas operations are emerging as a key strategic pillar for future growth.
Renewal works (retrofit and renovation) achieved orders of 102.3B yen (+26.5%), representing 41.8% of total orders. Both large-to-medium scale renovation (49.3B yen, +33.3%) and small-scale maintenance (53.0B yen, +20.8%) segments showed robust growth. The high renewal work ratio demonstrates the company's strong recurring revenue base from existing facility maintenance and upgrades.
Industrial facilities orders were 85.5B yen (+17.5%), representing 34.9% of total orders. While this segment maintains solid performance, its relative share is declining as overseas and renewal works expand more rapidly.
The dramatic improvement in operating income was broadly based across all segments, driven primarily by enhanced gross margins through appropriate pricing rather than specific segment mix shifts. The core Air-conditioning and Sanitation Works segment maintained stable volumes with improved margins, while Electrical Works provided incremental growth momentum.
Profitability: ROE 15.7% (prior period not directly comparable due to segment mix changes), Operating Margin 14.7% (up from 8.8%), Net Profit Margin 10.7% (up from 6.5%), Gross Profit Margin 23.1% (up from 15.6%). The 7.5 percentage point expansion in gross margin represents a fundamental improvement in project profitability.
DuPont 3-Factor ROE Analysis: Net Profit Margin 10.6%, Total Asset Turnover 0.884x, Financial Leverage 1.67x. The primary driver of ROE expansion is the dramatic improvement in net profit margin, reflecting operational excellence in project execution and pricing discipline.
Cash Quality: Operating CF 46.5B yen with Net Income 19.2B yen yields OCF/Net Income ratio of 2.42x, indicating strong cash conversion substantially exceeding earnings. This ratio well above 1.0x demonstrates high-quality earnings with robust cash generation.
Investment: Capital expenditures were modest relative to depreciation. Investment CF of -1.9B yen primarily reflects strategic investment in regenerative medicine business rather than traditional fixed asset expansion, suggesting measured capital intensity with focus on strategic diversification.
Financial Health: Equity Ratio 59.7% (up from 50.7%), Current Ratio 203.0%, Quick Ratio 203.0%, Interest-bearing Debt to Equity 2.8%. All metrics indicate strong financial stability with significant deleveraging achieved during the period.
Efficiency: Total Asset Turnover 0.884x, Accounts Receivable turnover cycle embedded in 66.7B yen of completed construction receivables relative to quarterly revenue of 180.2B yen suggests approximately 3.7-month collection period, typical for construction industry.
Operating CF: 46.5B yen, representing 2.42x coverage of Net Income (19.2B yen). The ratio well exceeding 1.0x indicates earnings are strongly backed by cash generation, demonstrating high-quality profitability. The substantial improvement from prior period operating CF of -13.0B yen reflects improved working capital management, particularly successful collection of accounts receivable and normalized project payment cycles.
Investing CF: -1.9B yen, primarily consisting of strategic investment in regenerative medicine business as part of portfolio diversification initiatives. The modest scale relative to operating CF indicates disciplined capital allocation without aggressive expansion spending. No major facility or equipment investments were executed during the period.
Financing CF: -67.2B yen, primarily comprising short-term borrowing repayments of approximately 20.2B yen and dividend payments. The substantial debt repayment was enabled by strong operating cash generation, representing intentional financial restructuring to reduce leverage and interest burden.
FCF: Approximately 44.6B yen (Operating CF 46.5B yen minus modest CapEx embedded in investing CF), representing robust free cash generation substantially exceeding net income. This provides ample capacity to fund dividends, debt repayment, and strategic investments.
Cash Position: Cash and deposits increased 17.0B yen to 68.8B yen (+32.9%), bringing Cash/Short-term Liabilities ratio to approximately 9.2% coverage. Combined with the 2.42x operating CF/net income ratio, cash generation capability is assessed as Strong, providing substantial financial flexibility for growth investments and shareholder returns.
Ordinary Income vs Net Income: Ordinary income of 27.6B yen declined to net income of 19.2B yen, a 30.4% reduction primarily attributable to normal income taxes of 8.9B yen (effective tax rate 31.7%). This gap is within expected parameters for normal tax burden and does not indicate earnings quality concerns.
Non-recurring Items: Extraordinary income of 0.5B yen (primarily 0.4B yen gain on investment securities sales) and extraordinary losses of 0.05B yen were minimal, representing only 0.3% of revenue. Non-operating income of 1.2B yen includes 0.5B yen foreign exchange gains and 0.4B yen investment securities sales gains, together representing 0.5% of revenue. These items are immaterial to overall earnings assessment.
Core Earnings Assessment: The dramatic improvement in profitability is fundamentally driven by operational factors—specifically the 7.5 percentage point expansion in gross profit margin through appropriate pricing and cost management. With minimal non-recurring items and operating CF substantially exceeding net income (2.42x coverage), earnings quality is assessed as high and sustainable.
Accruals Quality: Operating CF of 46.5B yen substantially exceeds Net Income of 19.2B yen, indicating negative accruals (cash earnings exceed accounting earnings). This is a strong positive signal for earnings quality. The company successfully converted accounts receivable to cash while maintaining healthy project pipelines, demonstrating effective working capital management without aggressive revenue recognition practices.
Full-year Guidance: Revenue 260.0B yen (-1.0% YoY), Operating Income 32.0B yen (+38.9%), Ordinary Income 32.3B yen (+37.6%), Net Income 23.1B yen. The guidance was revised upward by 4.0B yen for operating income from prior forecast, reflecting stronger-than-expected margin improvements.
Progress Rate vs Full-year Guidance: Q3 cumulative results represent 69.3% of revenue guidance (180.2B/260.0B), 82.9% of operating income guidance (26.5B/32.0B), 85.3% of ordinary income guidance (27.6B/32.3B), and 83.6% of net income guidance (19.2B/23.1B).
Against the standard 75% progress rate at Q3, revenue is tracking 6.3 percentage points behind (-6.3pp), while operating income is 7.9pp ahead, ordinary income is 10.3pp ahead, and net income is 8.6pp ahead. The profit progress rates significantly exceeding both the revenue progress rate and standard Q3 benchmark indicate the company is achieving margin expansion ahead of expectations.
The slower revenue progress reflects the timing nature of construction project completions, which typically concentrate in Q4 (fiscal year-end). The company forecasts Q4 revenue of approximately 79.8B yen to achieve full-year guidance. With order backlog at a record 323.2B yen and Q4 orders planned at 75.0B yen, the revenue target appears achievable.
Margin Assumptions: Full-year gross profit margin guidance of 21.2% (vs Q3 actual 23.1%) assumes some normalization in Q4, though still substantially improved from prior year's 15.8%. Operating margin guidance of 12.3% (vs Q3 actual 14.7%) similarly assumes Q4 moderation but reflects sustainable structural improvement in profitability.
The upward revision and strong profit progress rate validate management's execution on pricing discipline and cost management initiatives, supporting confidence in sustained margin improvement beyond current fiscal year.
Dividend Policy: The company announced a year-end dividend of 45 yen per share (post-split basis), bringing total annual dividend to 217 yen on a pre-split equivalent basis (including interim dividend of 52 yen pre-split and year-end 111 yen pre-split, equating to 72.3 yen post-split annual). Based on full-year net income guidance of 23.1B yen and current share count, the projected payout ratio is approximately 40.5%, aligning with management's stated dividend policy of "payout ratio 40% or higher and DOE (dividend on equity) floor of 4.8%."
Dividend Sustainability: With operating CF of 46.5B yen and FCF of approximately 44.6B yen substantially exceeding both net income (19.2B yen) and projected annual dividend payments (approximately 9.4B yen based on 130.1M shares outstanding), dividend coverage is robust at approximately 4.7x on an FCF basis. The strong cash generation capability and healthy balance sheet (equity ratio 59.7%, cash position 68.8B yen) provide ample capacity to sustain and potentially grow dividends.
The earlier XBRL-based calculation showing 117.2% payout ratio reflected interim period metrics rather than full-year guidance basis. On a full-year forecast basis with the announced dividend policy framework, the 40.5% payout ratio is conservative and sustainable.
Share Buybacks: No share buyback program was announced during the period. The company implemented a 3-for-1 stock split effective January 1, 2026 to enhance share liquidity, but this does not constitute share count reduction for return purposes.
Total Shareholder Return: The total return ratio (dividends only, no buybacks) of 40.5% indicates balanced capital allocation prioritizing dividend returns while retaining sufficient capital for growth investments and financial flexibility. The DOE floor of 4.8% provides downside protection for dividend stability even in periods of earnings volatility.
Near-term:
Long-term:
Industry Position (Reference - Proprietary Analysis)
Profitability: ROE 15.7% substantially exceeds Industry Median 3.7% (IQR: 1.7%-6.6%, n=4, 2025-Q3), placing the company in the top quartile. Operating Margin 14.7% significantly outperforms Industry Median 4.1% (IQR: 1.9%-5.8%, n=4), demonstrating superior operational efficiency and pricing power. Net Profit Margin 10.7% far exceeds Industry Median 2.8% (IQR: 1.3%-4.0%, n=4), reflecting both strong gross margins and efficient cost structure.
Financial Health: Equity Ratio 59.7% aligns closely with Industry Median 60.5% (IQR: 56.2%-67.8%, n=4), indicating balanced capital structure consistent with industry norms. Current Ratio 203.0% (2.03x) falls slightly below Industry Median 2.07x (IQR: 1.90x-3.18x), though remains well within healthy liquidity range.
Growth: Revenue Growth YoY -3.0% slightly underperforms Industry Median -3.5% (IQR: -13.7%-6.2%, n=4), though outperforms the lower quartile significantly. The company's revenue decline is less severe than industry bottom quartile while achieving substantially superior profit growth, indicating strategic focus on profitability optimization over volume.
Returns: Return on Assets at approximately 9.4% (annualized) substantially exceeds Industry Median 2.2% (IQR: 1.0%-3.6%, n=4), demonstrating superior asset utilization efficiency.
Overall Assessment: The company demonstrates best-in-class profitability metrics substantially outperforming industry medians across ROE, operating margin, and net margin, while maintaining industry-standard financial health. The profit margin expansion strategy has created significant competitive advantage in operational efficiency. Revenue performance is in line with industry trends showing sector-wide moderation, but the company's ability to expand margins during revenue decline indicates superior pricing discipline and cost management capabilities relative to peers.
Note: Industry comparisons based on construction sector (n=4 companies), 2025-Q3 period. Source: Proprietary analysis of publicly available earnings data.
Project Profitability Deterioration Risk: While gross margins improved dramatically to 23.1% in Q3, sustainability depends on continued ability to transfer rising labor and material costs to customers through appropriate pricing. Potential margin compression could result from intensified competitive bidding, cost inflation outpacing price escalation capability, or project execution issues. With 323.2B yen order backlog already contracted, pricing for these projects is largely locked in; future margin protection depends on new orders maintaining current pricing levels.
Working Capital and Collection Risk: Completed construction receivables of 66.7B yen and electronically recorded monetary claims of 8.3B yen represent substantial working capital deployed. Extended project payment cycles or client financial difficulties could constrain cash conversion despite strong operating CF in current period. The construction industry characteristically involves concentrated exposure to individual large projects, where single project payment delays can materially impact quarterly cash flows.
Short-term Liability Concentration Risk: While current ratio of 203.0% indicates adequate liquidity, short-term liabilities comprise 79.8% of total liabilities, creating potential refinancing risk if operating cash generation were to deteriorate or if financial market conditions tighten. Current accounts payable of 20.1B yen and advances received on construction contracts of 33.4B yen require continuous project execution and cash cycle management. The company has mitigated this risk through substantial cash holdings (68.8B yen) and reduction of short-term borrowings to minimal levels (2.8B yen), but the structural concentration in short-term liabilities warrants ongoing monitoring.
Fundamental Profitability Transformation: The company has achieved a structural shift in profitability, expanding gross margin by 7.5 percentage points to 23.1% and operating margin to 14.7% from 8.8%, driven by successful implementation of appropriate pricing strategies reflecting cost escalation. This margin expansion is backed by strong cash generation (Operating CF/Net Income ratio of 2.42x), validating the quality and sustainability of earnings improvement. The company's profitability metrics (ROE 15.7%, operating margin 14.7%, net margin 10.7%) substantially outperform industry medians, indicating competitive advantages in operational efficiency and pricing discipline.
Strategic Position Strengthening: Order backlog reached a record 323.2B yen (+24.4% YoY), with particularly strong growth in high-margin segments including overseas operations (+80.0% order growth, 20.1% of total), renewal works (41.8% of orders, +26.5% growth), and electrical works (+105.8%). The diversified order composition across renovation/maintenance (recurring revenue) and new construction (growth) provides balanced revenue visibility. The consolidation of Presico and expansion into Southeast Asian medical and research facility markets creates new growth avenues beyond domestic construction cyclicality.
Financial Flexibility for Sustained Returns: Strong cash generation (FCF approximately 44.6B yen) provides substantial capacity to fund dividends at 40.5% payout ratio (meeting stated policy of 40%+ payout and 4.8% DOE floor) while maintaining investment capacity for growth initiatives including digital transformation and overseas expansion. The reduction of interest-bearing debt to minimal levels (2.8% debt-to-equity) and improvement in equity ratio to 59.7% creates financial flexibility to pursue strategic opportunities. The balance between shareholder returns and retained earnings supports both near-term income expectations and long-term growth investments.
This report was automatically generated by AI integrating XBRL earnings data and PDF presentation materials as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.
AI analysis of PDF earnings presentation
In Q3 FY3/2026, Daidan Co., Ltd. reported orders received of 244,959 million yen (+19.0% YoY) and net sales of completed construction of 180,189 million yen (-3.0%). Orders reached a record high driven by large-scale overseas projects. Although completed construction declined due to the absence of prior-year large projects, appropriate price pass-through significantly improved the gross margin on completed construction to 23.1% (+7.5pp), resulting in sharp profit increases at all levels: operating income 26,525 million yen (+61.7%), ordinary income 27,553 million yen (+62.3%), and quarterly net income attributable to owners of parent 19,176 million yen (+58.6%). Full-year guidance was revised upward to operating income of 32,000 million yen (up 4,000 million yen from the previous forecast), ordinary income of 32,300 million yen, and net income of 23,100 million yen. The year-end dividend was also increased to 45 yen (135 yen on a pre-split basis), with an annual total of 217 yen (pre-split basis) expected.
Orders received reached a record 244,959 million yen (+19.0%) driven by bookings for large overseas healthcare-related facilities. The gross margin on completed construction improved significantly to 23.1% (15.6% in the prior year), delivering a step-change in profitability. Orders for overseas projects rose to 49,277 million yen (+80.0%), with the overseas order ratio expanding to 20.1%. Renewal works remained at a high level at 102,273 million yen (+26.5%), and order backlog reached a record 323,170 million yen (+24.4%). Annual dividend on a pre-split basis is 217 yen (payout ratio 40.5%), and operating CF improved sharply to 46,527 million yen.
Full-year net sales of completed construction are projected to edge down to 260,000 million yen (-1.0%), but improved project profitability underpins upward revisions to operating income of 32,000 million yen (+38.9%) and ordinary income of 32,300 million yen (+37.6%). The year-end order backlog is expected to remain high at 318,400 million yen, with a resilient order environment continuing, centered on renewal works and overseas projects. Contributions from the overseas business (Singapore, Thailand, Vietnam, Taiwan bases) and the consolidation of Presico are also expected to support medium-term growth beyond FY2026.
Management stated, “As customer understanding of appropriate price pass-through has progressed, profitability has improved and increased,” positioning gross margin expansion as the primary driver of earnings improvement. They are also executing wage increases linked to base pay hikes and DX investments (on-site operational efficiency and back-office automation), promoting the establishment of a sustainable growth platform through talent acquisition and operational efficiency. The dividend policy is “a payout ratio of 40% or higher and a DOE floor of 4.8%,” clearly identifying shareholder returns as the top management priority.
Based on the Declaration on Building Partnerships, payment terms for all suppliers were changed to full cash payment (effective for payments from January 20, 2026), strengthening co-prosperity across the supply chain. Continued DX investments to enhance on-site operational efficiency and streamline administrative tasks. Expansion of overseas business: consolidation of Singapore-based Presico and orders for large-scale medical and research facilities drove the overseas ratio to 20.1%. Maintained a 41.8% share of renewal works, reinforcing the foundation for a stock-type business. Diversified the business portfolio through an investment in regenerative medicine (investing CF: -1,885 million yen).
Order volatility risk due to postponements or cancellations of large industrial facility projects (the share of industrial facility orders declined to 34.9%). Cost pressure risks from foreign exchange and raw material price fluctuations. Collection risk on construction receivables (accounts receivable from completed construction of 667,380 million yen).